Clinical Trial Update: Anti-inflammatory Therapy for Recurrent In-stent Restenosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating anti-inflammatory therapy for recurrent in-stent restenosis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Snippet

Sponsor: Fu Wai Hospital, Beijing, China | Conditions: In-stent Restenosis | Phase 4 | Status: RECRUITING